{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:56:45Z","timestamp":1765886205122,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.surg.2019.11.007","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T17:46:45Z","timestamp":1577468805000},"page":"575-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-5218","authenticated-orcid":false,"given":"Marta","family":"Sandini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Lewosinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nie\u00dfen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilo","family":"Hackert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus W.","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0722-7286","authenticated-orcid":false,"given":"Simon","family":"Schimmack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2019.11.007_bib1","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2019.11.007_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2019.11.007_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1634\/theoncologist.2012-0434","article-title":"Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learned","volume":"18","author":"Yao","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.surg.2019.11.007_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000464292","article-title":"and the Antibe Consensus Conference participants. ENETS consensus guidelines for standard of care in neuroendocrine tumours: Surgery for small intestinal and pancreatic neuroendocrine tumours","volume":"105","author":"Partelli","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.surg.2019.11.007_bib5","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/SLA.0000000000002123","article-title":"A\u00a0new scoring system to predict recurrent disease in grade 1 and 2 nonfunctional pancreatic neuroendocrine tumors","volume":"267","author":"Genc","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2019.11.007_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ejso.2018.03.005","article-title":"The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms","volume":"44","author":"Partelli","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2019.11.007_bib7","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.3748\/wjg.15.5274","article-title":"Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans","volume":"15","author":"Jamal","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2019.11.007_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canep.2018.04.008","article-title":"Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK","volume":"54","author":"de Jong","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.surg.2019.11.007_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","article-title":"Probability of pancreatic cancer following diabetes: a population-based study","volume":"129","author":"Chari","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2019.11.007_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2019.11.007_bib11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1245\/s10434-013-3415-6","article-title":"Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis","volume":"21","author":"Walter","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2019.11.007_bib12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.surg.2019.11.007_bib13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2337\/db16-1477","article-title":"Diabetes, pancreatogenic diabetes, and pancreatic cancer","volume":"66","author":"Andersen","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.surg.2019.11.007_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/annonc\/mdv505","article-title":"Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis","volume":"27","author":"Leoncini","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.surg.2019.11.007_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1042\/CS20090399","article-title":"Insulin resistance and hyperinsulinaemia in the development and progression of cancer","volume":"118","author":"Godsland","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.surg.2019.11.007_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000362339","article-title":"New insights into the role of chronic inflammation and cytokines in the etiopathogenesis of gastroenteropancreatic neuroendocrine tumors","volume":"99","author":"Cigrovski Berkovic","year":"2014","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.surg.2019.11.007_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.gastro.2018.04.010","article-title":"Metformin use is associated with longer progression-free survival of patients with diabetes and pancreatic neuroendocrine tumors receiving everolimus and\/or somatostatin analogues","volume":"155","author":"Pusceddu","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2019.11.007_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-17-0040","article-title":"Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms","volume":"24","author":"Valente","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.surg.2019.11.007_bib19","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"year":"2010","series-title":"WHO Classification of Tumours of the Digestive System","key":"10.1016\/j.surg.2019.11.007_bib20"},{"key":"10.1016\/j.surg.2019.11.007_bib21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/bjs.10842","article-title":"Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail","volume":"105","author":"Hank","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2019.11.007_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.surg.2019.11.007_bib23","first-page":"141","article-title":"Epidemiology and risk factors of pancreatic cancer","volume":"89","author":"Capasso","year":"2018","journal-title":"Acta Biomed"},{"key":"10.1016\/j.surg.2019.11.007_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.bjc.6601140","article-title":"A\u00a0meta-analysis of obesity and the risk of pancreatic cancer","volume":"89","author":"Berrington de Gonzalez","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surg.2019.11.007_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13046-018-0963-4","article-title":"Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting","volume":"37","author":"Pothuraju","year":"2018","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.surg.2019.11.007_bib26","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.surg.2019.11.007_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4093\/dmj.2014.38.5.330","article-title":"Hyperglycemia as a risk factor for cancer progression","volume":"38","author":"Ryu","year":"2014","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.surg.2019.11.007_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2019.07.003","article-title":"Endogenous hyperinsulinemia contributes to pancreatic cancer development","volume":"30","author":"Zhang","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.surg.2019.11.007_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/carcin\/bgx150","article-title":"Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms","volume":"39","author":"Obazee","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.surg.2019.11.007_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.surg.2019.11.007_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"and the Consotrium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.surg.2019.11.007_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejim.2012.12.017","article-title":"Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease?","volume":"24","author":"Ewald","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.surg.2019.11.007_bib33","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1053\/j.gastro.2012.08.044","article-title":"Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in beta cells and mice","volume":"143","author":"Aggarwal","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2019.11.007_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","article-title":"Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer","volume":"134","author":"Chari","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2019.11.007_bib35","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/eurheartj\/ehv008","article-title":"and the EUROASPIRE IV Investigators. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV\u2013a survey from the European Society of Cardiology","volume":"36","author":"Gyberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.surg.2019.11.007_bib36","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1038\/ajg.2009.466","article-title":"Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients","volume":"104","author":"Capurso","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.surg.2019.11.007_bib37","doi-asserted-by":"crossref","first-page":"36073","DOI":"10.1038\/srep36073","article-title":"Risk factors for sporadic pancreatic neuroendocrine tumors: A case-control study","volume":"6","author":"Ben","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.surg.2019.11.007_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.metabol.2017.09.013","article-title":"Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes","volume":"78","author":"Gallo","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.surg.2019.11.007_bib39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10549-016-3696-0","article-title":"High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation","volume":"155","author":"Huang","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.surg.2019.11.007_bib40","doi-asserted-by":"crossref","first-page":"e3138","DOI":"10.1038\/cddis.2017.512","article-title":"Phosphoprotein enriched in diabetes (PED\/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib","volume":"8","author":"Quintavalle","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.surg.2019.11.007_bib41","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1159\/000373928","article-title":"High glucose promotes tumor invasion and increases metastasis-associated protein expression in human lung epithelial cells by upregulating heme oxygenase-1 via reactive oxygen species or the TGF-beta1\/PI3K\/Akt signaling pathway","volume":"35","author":"Kang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.surg.2019.11.007_bib42","doi-asserted-by":"crossref","first-page":"38539","DOI":"10.18632\/oncotarget.9533","article-title":"Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.surg.2019.11.007_bib43","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","article-title":"Repurposing metformin for the prevention of cancer and cancer recurrence","volume":"60","author":"Heckman-Stoddard","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.surg.2019.11.007_bib44","doi-asserted-by":"crossref","first-page":"25242","DOI":"10.18632\/oncotarget.15692","article-title":"Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606019307433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606019307433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:53:50Z","timestamp":1758538430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606019307433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0039606019307433"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2019.11.007","relation":{},"ISSN":["0039-6060"],"issn-type":[{"type":"print","value":"0039-6060"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2019.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}